Anti-fibrotic agent in Endonasal Lacrimal Sac Surgery.
Not Applicable
- Conditions
- Health Condition 1: null- Primary Acquired Nasolacrimal Duct Obstruction
- Registration Number
- CTRI/2014/09/004989
- Lead Sponsor
- Hyderabad Eye Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 440
Inclusion Criteria
1.Adult patients ( >18 years)
2.Presence of regurgitation on pressure over lacrimal sac and/or regurgitation admixed with mucopurulent debris on syringing.
3.Patients who have a hard stop on probing
4.Normal eyelid function
Exclusion Criteria
1.Patients undergoing revision DCR
2.Paediatric patients ( <18 years)
3.NLDO secondary to trauma
4.Presence of any canalicular obstruction/eyelid condition responsible for epiphora
5.Anemia ( Hb < 7 gram%) or deranged coagulation profile
6.Presence of significant nasal pathology like deviated nasal septum, nasal polyps.
7.Patients who agree to visit the institute for 1 year or more after surgery.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method